Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill Patient.

Paul M Reynolds Edward T Van MatreGarth C WrightRobert Brett McQueenEllen L BurnhamPei Jai Michael HoMarc MossRobert William VandivierTyree Heath Kisernull null

Published in: Pharmacotherapy (2019)

In critically ill patients, prophylactic dosing of heparin 3 times/day versus twice/day was not associated with differences in new VTE or safety outcomes. Several modifiable VTE risk factors were identified.

Keyphrases

venous thromboembolism
risk factors
direct oral anticoagulants
case report
type diabetes
atrial fibrillation
adipose tissue
growth factor
insulin resistance